#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14712	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2475	732.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1881	1881	T	927	T,G	925,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14712	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2475	732.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1615	1615	C	969	C,T	968,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25050	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4022	776.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1919	1919	A	1023	A,C	1022,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25050	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4022	776.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2553	2553	C	837	C,A,T	833,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25050	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4022	776.4	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3179	3179	T	863	T,G	861,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	25050	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4022	776.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2627	2627	A	794	A,C	793,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	G5V	NONSYN	13	15	GGT	524	526	GTT	148;147;147	G;T;T	148;147;147	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	E12K	NONSYN	34	36	GAA	545	547	AAA	158;161;160	A;A;A	158;161;160	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	F31L	NONSYN	91	93	TTT	602	604	TTG	192;194;197	T;T,G;G	192;193,1;197	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	K42Q	NONSYN	124	126	AAA	635	637	CAA	230;225;226	CAAA,CAA;A;A	219,1;225;225	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	S75P	NONSYN	223	225	TCC	734	736	CCT	207;207;207	C,T;C;T	206,1;207;207	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	V87A	NONSYN	259	261	GTA	770	772	GCA	174;174;172	G;C,T;A	174;173,1;172	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	V130L	NONSYN	388	390	GTC	899	901	CTC	202;205;205	C;T,G;C,A	202;204,1;204,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	R135C	NONSYN	403	405	CGC	914	916	TGT	205;206;206	T,A;G,A,T;T,G	204,1;204,1,1;205,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	T137A	NONSYN	409	411	ACG	920	922	GCG	206;207;209	G;C;G,T	206;207;208,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	E151K	NONSYN	451	453	GAA	962	964	AAG	212;214;216	A;A;G	212;214;215	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	T152N	NONSYN	454	456	ACC	965	967	AAT	216;218;223	A;A,C;T	215;216,1;222	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	F218L	NONSYN	652	654	TTT	1163	1165	TTG	136;136;135	T;T;G	136;136;135	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	1	SNP	p	R228S	1	R228S	NONSYN	682	684	CGT	1193	1195	AGC	120;120;121	A;G;C	120;120;121	folP.Neisseria_meningitidis_M01_240149_v1_00504:1:1:R228S:folP.228S:Resistance to sulphonamides	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	V251L	NONSYN	751	753	GTG	1262	1264	CTG	100;100;101	C;T;G,T	100;100;100,1	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	A253S	NONSYN	757	759	GCT	1268	1270	TCC	98;98;98	T;C;C	98;98;98	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	A258V	NONSYN	772	774	GCG	1283	1285	GTG	112;113;114	G;T;G	112;113;114	.	.
folP.Neisseria_meningitidis_M01_240149_v1_00504	folP.Neisseria_meningitidis_M01_240149_v1_00504	1	1	539	1778	folP	852	852	93.78	folP.l15.c4.ctg.1	1979	111.9	0	.	p	.	0	V275A	NONSYN	823	825	GTG	1334	1336	GCG	152;149;147	G,T,A;C;G	150,1,1;149;147	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5476	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3710	183.7	1	SNP	p	S91F	0	.	.	271	273	TCC	728	730	TCC	197;197;196	T;C;C,A	197;197;195,1	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5476	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3710	183.7	1	SNP	p	D95N	0	.	.	283	285	GAC	740	742	GAC	195;194;192	G;A;C	195;194;192	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5476	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3710	183.7	1	SNP	p	D95G	0	.	.	283	285	GAC	740	742	GAC	195;194;192	G;A;C	195;194;192	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_M_01390	mtrR.WHO_M_01390	1	1	531	1954	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1782	136.7	0	.	p	.	0	Q133trunc	TRUNC	397	397	C	1037	1037	T	210	T	210	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	1078	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1579	85.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4870	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3302	183.9	0	.	p	.	0	V384I	NONSYN	1150	1152	GTC	1653	1655	ATC	216;216;216	A;T,C;C	216;215,1;216	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4870	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3302	183.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1806	1808	GCA	229;229;227	G;C;A	229;229;227	.	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4870	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3302	183.9	1	SNP	p	D86N	0	.	.	256	258	GAC	759	761	GAC	236;238;235	G,T;A;C	235,1;238;235	parC.WHO_G_00206c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4870	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3302	183.9	1	SNP	p	S87I	0	.	.	259	261	AGT	762	764	AGT	234;234;234	A,C;G;T,C	232,2;234;233,1	parC.WHO_G_00206c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4870	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3302	183.9	1	SNP	p	S87R	0	.	.	259	261	AGT	762	764	AGT	234;234;234	A,C;G;T,C	232,2;234;233,1	parC.WHO_G_00206c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4870	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3302	183.9	1	SNP	p	S87W	0	.	.	259	261	AGT	762	764	AGT	234;234;234	A,C;G;T,C	232,2;234;233,1	parC.WHO_G_00206c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_G_00206c	parC.WHO_G_00206c	1	1	539	4870	parC	2304	2304	99.74	parC.l15.c4.ctg.1	3302	183.9	1	SNP	p	S88P	0	.	.	262	264	TCC	765	767	TCC	235;231;231	T,A;C;C,T	233,2;231;230,1	parC.WHO_G_00206c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4330	parE	1986	1986	99.95	parE.l15.c17.ctg.1	3014	178.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1752	1754	GGC	254;253;251	G,T;G,T;C	253,1;252,1;251	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1510	1512	GCA	239;241;240	G;C,G;A	239;240,1;240	penA.14.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1513	1515	ATC	242;240;244	A;T,A;C	242;239,1;244	penA.14.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1525	1527	GTG	240;245;245	G;T,A;G	240;244,1;245	penA.14.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1525	1527	GTG	240;245;245	G;T,A;G	240;244,1;245	penA.14.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2029	2031	ACC	254;254;255	A;C;C	254;254;255	penA.14.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2083	2085	GCG	243;244;243	G,T;C;G,C	242,1;244;242,1	penA.14.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2083	2085	GCG	243;244;243	G,T;C;G,C	242,1;244;242,1	penA.14.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2206	2208	GGT	229;232;234	G;G;T,A	229;232;233,1	penA.14.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2215	2217	GGC	232;231;231	G;G;C	232;231;231	penA.14.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.14.001	penA.14.001	1	1	27	4114	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2893	177.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2233	2235	CCG	221;220;220	C;C;G,A	221;220;219,1	penA.14.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5768	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3579	200.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2370	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2204	134.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	563	565	GGC	161;160;162	G,C;G;C	160,1;160;162	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2370	porA	1146	1146	99.74	porA.l15.c4.ctg.1	2204	134.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	745	745	C	187	C	187	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	29;33;35	T;T;A	29;33;35	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	69;69;69	C;A;T	69;69;69	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	69;69;69	A;G;T	69;69;69	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	69;69;69	T,C;A;C	68,1;69;69	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	R307E	NONSYN	919	921	AGA	161	163	GAA	2;2;2	G;A;A	2;2;2	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	4;4;4	G;C;A	4;4;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	5;5;5	A;T;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	5;5;5	T;C;G	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	5;5;5	G;C;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	5;5;5	A;G;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	5;6;6	G;C;C	5;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	528	324	porB1a	984	226	90.71	porB1a.l15.c17.ctg.2	304	34.8	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	6;6;6	G;T;T	6;6;6	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3024	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2058	183.1	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1175	1175	T	253	T	253	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3024	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2058	183.1	1	SNP	p	G120K	0	.	.	358	360	GGT	902	904	GGT	240;241;240	G;G;T,G	240;241;239,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3024	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2058	183.1	1	SNP	p	A121N	0	.	.	361	363	GCC	905	907	GCC	239;241;242	G;C;C	239;241;242	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	3024	porB1b	1035	1035	98.66	porB1b.l6.c4.ctg.1	2058	183.1	1	SNP	p	A121D	0	.	.	361	363	GCC	905	907	GCC	239;241;242	G;C;C	239;241;242	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10284	rpoB	4179	4179	99.95	rpoB.l6.c4.ctg.1	5468	234.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1440	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1502	119.3	1	SNP	p	V57M	1	.	.	169	171	ATG	686	688	ATG	258;259;260	A;T;G,T	258;259;259,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
